Want to join the conversation?
$GILD 2Q15 Call: 83% of genotype 1 patients have direct access to Harvoni, a percentage that has remained stable since 1Q15. In Europe, hepatitis C revenue was more than $1.1Bil, with over 30,000 estimated new patient starts. Saw particularly high patient initiations in Spain, Italy and Portugal during the quarter.
$CIEN a good stock to look at for the longs. Consistent revenue increase over the past few quarters suggest steady improvement in profitability of the company, which bodes well for the future prospect. I’m going to add a few more to my portfolio, anticipating good $$$ gains !
Shareholder alert..!! Rosen Law Firm has commenced an investigation into potential securities claims of $UHS. Shareholders please visit http://www.rosenlegal.com/cases-1008.html for more info.
Can we see "Made in the USA" label on iPhones in the near future? Heard that $AAPL is considering the idea of manufacturing iPhone in America.
People who are looking for a steady growth stock should take a look at $EME. This stock has never had a significant downfall in the last five years. Comfortably beats consensus target most of the time. Such potential, much wow!
Looks like Creative Planning jumped on the bandwagon! Increased its stake by 91% in $EWBC. A lot of companies recently raised their stack too. I smell something’s cooking.